SELLAS to present preclinical data on SLS009 at AACR conference

March 17, 2026 4:30 PM

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) announced that preclinical data on SLS009, its CDK9 inhibitor drug candidate, will be ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found